GlassScriptPhysician profile
Michaela Bosico
NPI 1619671732
$4,877.43
in general payments reported to CMS, 2019-2025
11 companies · $2,807 in 2025
The $2,807 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $431 · 2024: $1,639 · 2025: $2,807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,872 · Travel and Lodging: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,871.85 |
| Travel and Lodging | $1,005.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,969.36 | 2023-2025 | Augment Injectable, Infinity Adaptis, Prostep Mica |
| Novus Surgical Consultants | $1,284.60 | 2023-2025 | |
| Arthrex, INC. | $651.40 | 2025 | |
| Smith+Nephew, INC. | $328.94 | 2023-2025 | Grafix Pl, Stravix Pl, Oasis |
| Amgen INC. | $224.40 | 2024-2025 | Krystexxa |
| Alexion Pharmaceuticals, INC. | $124.74 | 2024 | Strensiq |
| International Life Sciences | $121.22 | 2024 | Flexband |
| Depuy Synthes Sales INC. | $57.15 | 2025 | Na |
| Treace Medical Concepts, INC. | $56.25 | 2024 | |
| Kuros Biosciences USA, INC | $36.01 | 2025 | Magnetos |
| Acumed LLC | $23.36 | 2025 | Acumed, Innate Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michaela Bosico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.